Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures: Potential role in fibrosis

Archives of Dermatology

Volumn 132, Issue 7, 1996, Pages 802-806

  Salmon Ehr, Véronique ^a   Serpier, Hervé ^a   Nawrocki, Béatrice ^a   Gillery, Philippe ^a   Clavel, Christine ^a   Kalis, Bernard ^a   Birembaut, Philippe ^a   Maquart, François Xavier ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 4; MESSENGER RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SCLERODERMA; SKIN BIOPSY; SKIN FIBROSIS;

ADULT; AGED; CELLS, CULTURED; FEMALE; FIBROBLASTS; FIBROSIS; HUMANS; INTERLEUKIN-4; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; SKIN;

EID: 0029941568     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.132.7.802     Document Type: Article

References (26)

1. Fleischmajer R. Perlish JS, Duncan M. Scleroderma: a model for fibrosis. Arch Dermatol. 1993;119:957-967.
2. Maquart F-X, Gillery P, Kalis B, Borel JP. Cytokines and fibrosis. Eur J Dermatol. 1994;4:91-97.
3. Sporn MB, Roberts AB. Transforming growth factor β: recent progress and new challenges. J Cell Biol. 1992;119:1017-1021.
4. Gillery P, Leperre A, Maquart F-X, Borel JP. Insulin-like growth factor I (IGF-I) stimulates protein synthesis and collagen gene expression in monolayer and lattice cultures of fibroblasts. J Cell Physiol. 1992;152:389-396.
5. Feghali CA, Bost KL, Boulware DW, Levy LS. Mechanisms of pathogenesis in scleroderma, I: overproduction of interleukin-6 by fibroblasts cultured from affected skin sites of patients with scleroderma. J Rheumatol. 1992;19:1207-1211
6. Kahaleh MB. Endothelin, an endothelial-dependent vasoconstrictor in scleroderma. Arthritis Rheum. 1991;34:978-983.
7. Fertin C, Nicolas JF, Gillery P, Kalis B, Banchareau J, Maquart F-X. Interleukin-4 stimulates collagen synthesis by normal and scleroderma fibroblasts in dermal equivalents. Cell Mol Biol (Noisy-le-grand). 1991;37:823-829.
8. Gillery P, Fertin C, Nicolas JF, et al. lnterleukin-4 stimulates collagen gene expression in human fibroblast monolayer cultures: potential role in fibrosis. FEBS Lett. 1992;302:231-234.
9. Postlethwaite AE, Holness MA, Katai H, Raghow R. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin-4. J Clin Invest. 1992;90:1479-1485.
10. Peyron E, Banchereau J. lnterleukin-4: structure, function and clinical aspects. Eur J Dermatol. 1994;4:181-188.
11. Wegrowski J, Paltot V, Gillery P, Kalis B, Randoux A, Maquart F-X. Stimulation of sulphated glycosaminoglycan and decorin production in adult dermal fibroblasts by recombinant human interleukin-4. Biochem J. 1995;307:673-678.
12. Fleischmajer R, Perlish JS, Reeves JRT. Cellular infiltrates in scleroderma skin. Arthritis Rheum. 1977;20:975-984.
13. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980; 23:581-590.
14. Clavel C, Doco M, Lallemand A, Laurent M, Birembaut P. Detection by in situ hybridization of messenger RNAs of collagen types I and IV in murine mammary cancer. Int J Cancer. 1989;44:548-553.
15. Yokota T, Otsuka T, Mosmann T, et al. Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities. Proc Natl Acad Sci U S A. 1986;83:5894-5898.
16. Schwartz D. Méthodes statistiques à l'usage des biologistes. 3rd ed. Paris, France: Flammarion Médecine Sciences; 1964.
17. Gruschwithz M, Müller PV, Sepp N, Hofer E, Fontana A, Wick G. Transcription and expression of transforming growth factor β in the skin of progressive systemic sclerosis: a mediator of fibrosis? J Invest Dermatol. 1990;94:197-203.
18. Kulozik M, Hogg A, Laukatt-Buttgereit B, Krieg T. Co-localization of transforming growth factor β2 with α1(l) procollagen mRNA in tissue sections of patients with systemic sclerosis. J Clin Invest. 1990;86:917-922.
19. Gabrielli A, Di Loreto C, Taborro R. et al. Immunohistochemical localization of intracellular and extracellular associated TGF-β in the skin of patients with systemic sclerosis (scleroderma) and primary Raynaud's phenomenon. Clin Immunol Immunopathol. 1993;68:340-349.
20. Highley H, Persichitte K, Chu S, Waegell W, Vancheeswaran R, Black C. Immunocytochemical localization and serologic detection of transforming growth factor β1: association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon Arthritis Rheum. 1994;37:278-288
21. Mauch C, Eckes B, Hunzelmann N, Oono T, Kozlowska E, Krieg T. Control of fibrosis in systemic scleroderma. J Invest Dermatol. 1993;100:925-965.
22. Lacraz S. Nicod L, Galve de Rochemonteix B, Baumberger C, Dayer JM, Welgus HG. Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J Clin Invest. 1992;90:382-388.
23. Takeda K, Hatamochi A, Veki H, Nakata M, Oishi Y. Decreased collagenase expression in cultured systemic sclerosis fibroblasts. J Invest Dermatol. 1994; 103:359-363.
24. Fleischmajer R, Perlish JS, West WP. Ultrastructure of cutaneous infiltrates in scleroderma. Arch Dermatol. 1977;113:1661-1666.
25. Claman HN. On scleroderma: mast cells, endothelial cells, and fibroblasts. JAMA. 1989;262:1206-1209.
26. + T cells in the pathogenesis of skin fibrosis in tight skin mice. Eur J Immunol. 1994;24:1463-1466.